Sleep Science: Feb 1-7, 2026

Researchers developed an AI-powered patch-type heart rate variability (HRV) analyzer that achieved 81.4% accuracy in screening moderate-to-severe OSA (AHI≥15). The device introduces a novel Cardiovascular Hypopnea Index (CVHI) using ECG amplitude features and nonlinear analysis, significantly outperforming demographic-based screening (73%) and previous ECG-based methods (70.6%). The comfortable, wearable device can continuously monitor for up to one week without significantly disrupting sleep.

Traditional sleep studies are cumbersome and often delayed. This wearable option could expand access to OSA screening and help identify high-risk patients faster. For patients avoiding in-lab studies due to discomfort or inconvenience, patch-type devices offer a practical alternative with strong accuracy.

An 8-week online mindfulness-based cognitive therapy for insomnia (iMBCT-I) program achieved a 56.10% remission rate in 82 adults with chronic insomnia disorder, significantly outperforming sleep hygiene education (17.07%). The therapy combined mindfulness practices with CBT-I techniques, showing sustained benefits at 20-week follow-up including improved sleep quality, reduced sleep onset latency, better sleep efficiency, and enhanced quality of life. Over 90% of participants said they would recommend the program to others.

Chronic insomnia is common and often undertreated. Accessible, evidence-based digital interventions can reach people who cannot access in-person therapy. For those who have struggled with insomnia for months, therapist-guided online programs offer real hope with strong remission rates.

This study of 790 OSA patients combined with genetic analysis challenges the assumption that sleep apnea directly causes blood clotting problems. While severe OSA patients showed higher fibrinogen levels and shorter clotting times, these associations disappeared after accounting for body weight. Genetic evidence found no causal link between OSA and coagulation markers, suggesting obesity - not OSA itself - drives thrombotic risk. This finding has major implications for treatment priorities.

This reframes how we approach cardiovascular risk in OSA patients. Weight management may be more effective than CPAP alone for reducing clot risk. For overweight patients with OSA, focus on sustainable weight loss alongside CPAP therapy.

Duke University researchers are testing a novel 9-week telehealth intervention (PASS) that combines behavioral parent training with sleep medicine for preschoolers (ages 3-5) at risk for ADHD. The program targets both daytime behaviors and nighttime sleep regulation, recognizing that sleep problems affect 2-in-3 young children with ADHD symptoms and may worsen developmental trajectories. The study uses objective sleep measurement via actigraphy and aims to prevent ADHD by addressing sleep as a key biological mechanism during a critical developmental window.

Early intervention that addresses sleep and behavior together could change developmental outcomes. For parents of preschoolers with attention or sleep difficulties, seeking integrated programs may prevent ADHD from fully developing.